Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. (EWTX) Stock Overview

Explore Edgewise Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

EWTX●NASDAQ
HealthcareBiotechnology
$44.62
$0.22(0.50%)
U.S. Market opens in NaNh NaNm

Edgewise Therapeutics, Inc. (EWTX)

Meyka AI Score

Z

Key Financials

Market Cap4.8B
P/E Ratio-24.19
EPS (TTM)$-1.85
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$42.60
3 Months$63.17
1 Year Target$35.51

EWTX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Edgewise Therapeutics, Inc. (NASDAQ: EWTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Edgewise Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EWTX on the NASDAQ shows an RSI of 56.72, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $35.51 for the NASDAQ listing.

Key metrics behind Edgewise Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -24.19 and a market capitalization of 4.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EWTX on the NASDAQ.

Price Performance (NASDAQ: EWTX)

1-Day Change
0.50%
5-Day Change
3.70%
1-Month Change
1.02%
3-Month Change
28.11%
6-Month Change
50.79%
Year-to-Date (YTD) Change
79.77%
1-Year Change
225.69%
3-Year Change
563.001%
5-Year Change
163.87%
All-Time (Max) Change
48.73%

Contact Information

https://www.edgewisetx.com
303 735 8373
1715 38th Street, Boulder, CO, 80301

Company Facts

1,270 Employees
IPO DateMar 26, 2021
CountryUS
Actively Trading

Frequently Asked Questions